LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
Clinical trial NCT06351020 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06351020
- Sponsor
- LaNova Medicines Zhejiang Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2026-11-10
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.